Skip to main navigation
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2025
Resources
All Resources
2024 Savings Report
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Search
Close
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Report
Apr 16, 2018
| Erica Klinger
2016 Savings and Access Report
Report
Feb 12, 2018
| Erica Klinger
2017 AAM Annual Report
Report
Feb 9, 2018
| Erica Klinger
AAM White Paper: Ensuring the Future of Accessible Medicines in the U.S.
Report
Jan 4, 2018
| Erica Klinger
7 Policy Solutions
Report
Oct 12, 2017
| Erica Klinger
AAM White Paper: Renting Tribal Immunity to Evade IPR Review of Pharmaceutical Patents
Report
Sep 18, 2017
| Erica Klinger
Bates-White Report: CPI-Based Medicaid Rebates Harm Generic Competition
Report
Aug 22, 2017
| Erica Klinger
Poll Results: California Proposed Drug Pricing Law (SB 17)
Report
Jul 25, 2017
| Erica Klinger
2017 Generic Drug Access and Savings Report
Report
Jul 20, 2017
| Rebecca Rodrigues
2016 Annual Report
Report
Jun 17, 2017
| Erica Klinger
REMS and Restricted Distribution Programs
Report
Jan 1, 2016
| Erica Klinger
2015 Annual Report
Report
Jan 1, 2015
| Erica Klinger
2014 Annual Report
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2025
Resources
All Resources
2024 Savings Report
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action